Clinical trial
A Retrospective Multicenter Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A (Result Study)
NCT04340336 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Retrospective Multicenter Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A (Result Study)
- Lead sponsor
- Ipsen
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 21, 2020
- Completion date
- October 31, 2021
- Enrollment
- 150 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
spasticity